📣 VC round data is live. Check it out!

EBM Technologies Valuation Multiples

Discover revenue and EBITDA valuation multiples for EBM Technologies and similar public comparables like Diagnos, Micro-X, MRSO, CareView Communications and more.

EBM Technologies Overview

About EBM Technologies

EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.


Founded

1988

HQ

Taiwan

Employees

116

Financials (FY)

Revenue: $8M
EBITDA: $913K

EV

$17M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

EBM Technologies Financials

EBM Technologies reported last fiscal year revenue of $8M and EBITDA of $913K.

In the same fiscal year, EBM Technologies generated $6M in gross profit, $913K in EBITDA, and $249K in net income.


EBM Technologies P&L

In the most recent fiscal year, EBM Technologies reported revenue of $8M and EBITDA of $913K.

EBM Technologies is profitable as of last fiscal year, with gross margin of 69%, EBITDA margin of 11%, and net margin of 3%.

See analyst estimates for EBM Technologies
Last FY202320242025202620272028
Revenue$8M$7M$9M$8M
Gross Profit$6M$5M$6M$6M
Gross Margin69%75%63%69%
EBITDA$913K$120K$736K$913K
EBITDA Margin11%2%8%11%
EBIT Margin4%(7%)1%4%
Net Profit$249K($447K)$68K$249K
Net Margin3%(7%)1%3%

Financial data powered by Morningstar, Inc.

EBM Technologies Stock Performance

EBM Technologies has current market cap of $20M, and enterprise value of $17M.

Market Cap Evolution


EBM Technologies' stock price is $0.61.

EBM Technologies share price increased by 0.5% in the last 30 days, and decreased by 17.3% in the last year.

EBM Technologies has an EPS (earnings per share) of $0.01.

See more trading valuation data for EBM Technologies
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$17M$20M1.1%0.5%-5.6%-17.3%$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

EBM Technologies Valuation Multiples

EBM Technologies trades at 2.2x EV/Revenue multiple, and 19.1x EV/EBITDA.

See NTM and 2027E valuation multiples for EBM Technologies

EBM Technologies Financial Valuation Multiples

As of June 4, 2026, EBM Technologies has market cap of $20M and EV of $17M.

EBM Technologies has a P/E ratio of 78.4x.

Last FY202320242025202620272028
EV/Revenue2.2x2.7x1.9x2.2x
EV/EBITDA19.1x144.8x23.7x19.1x
EV/EBIT56.1x(38.1x)163.6x56.1x
EV/Gross Profit3.1x3.5x3.1x3.1x
P/E78.4x(43.6x)n/m78.4x
EV/FCF(7.3x)(45.1x)4.6x(7.3x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified EBM Technologies Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

EBM Technologies Margins & Growth Rates

In the most recent fiscal year, EBM Technologies reported gross margin of 69%, EBITDA margin of 11%, and net margin of 3%.

See estimated margins and future growth rates for EBM Technologies

EBM Technologies Margins

Last FY20242025202720282029
Gross Margin69%63%69%
EBITDA Margin11%8%11%
EBIT Margin4%1%4%
Net Margin3%1%3%
FCF Margin(30%)42%(30%)

EBM Technologies Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth36%(10%)
Gross Profit Growth15%(2%)
EBITDA Growth511%24%
EBIT Growth(123%)192%
Net Profit Growth(115%)264%
FCF Growth(1079%)(163%)

Data powered by FactSet, Inc. and Morningstar, Inc.

EBM Technologies Operational KPIs

EBM Technologies' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for EBM Technologies
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.0M---
S&M Expenses to Revenue22%28%21%22%
G&A Expenses to Revenue22%30%22%22%
R&D Expenses to Revenue21%24%18%21%
Opex to Revenue65%82%62%65%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EBM Technologies Competitors

EBM Technologies competitors include Diagnos, Micro-X, MRSO, CareView Communications, SenzaGen, NextPlat, Biosynex, CurveBeam AI, Cambridge Cognition and Metacare.

Most EBM Technologies public comparables operate across Healthcare Software, Medical Imaging & Diagnostics, B2B SaaS, HealthTech and Vertical SaaS.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Diagnos243.5x-(7.1x)-
Micro-X2.0x1.0x(2.4x)(4.7x)
MRSO1.2x1.2x(44.7x)-
CareView Communications----
SenzaGen2.6x-(18.1x)-
NextPlat0.2x-(1.3x)-
Biosynex0.8x-60.1x-
CurveBeam AI2.9x3.2x(3.5x)(3.5x)

This data is available for Pro users. Sign up to see all EBM Technologies competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About EBM Technologies

When was EBM Technologies founded?EBM Technologies was founded in 1988.
Where is EBM Technologies headquartered?EBM Technologies is headquartered in Taiwan.
How many employees does EBM Technologies have?As of today, EBM Technologies has over 116 employees.
Is EBM Technologies publicly listed?Yes, EBM Technologies is a public company listed on Taipei Exchange.
What is the stock symbol of EBM Technologies?EBM Technologies trades under 8409 ticker.
When did EBM Technologies go public?EBM Technologies went public in 2012.
Who are competitors of EBM Technologies?EBM Technologies main competitors include Diagnos, Micro-X, MRSO, CareView Communications, SenzaGen, NextPlat, Biosynex, CurveBeam AI, Cambridge Cognition, Metacare.
What is the current market cap of EBM Technologies?EBM Technologies' current market cap is $20M.
What is the current revenue of EBM Technologies?EBM Technologies' last fiscal year revenue is $8M.
What is the current EV/Revenue multiple of EBM Technologies?Current revenue multiple of EBM Technologies is 2.2x.
Is EBM Technologies profitable?No, EBM Technologies is not profitable.
How many companies EBM Technologies has acquired to date?EBM Technologies hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies EBM Technologies has invested to date?EBM Technologies hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to EBM Technologies

Lists including EBM Technologies

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial